Loading...
Although minimally invasive (laparoscopic, including robotic) approaches have been shown to improve perioperative outcomes for benign and malignant gynecologic conditions, the move away from open surgical approaches (laparotomy) was jump-started by the FDA's approval of robotic hysterectomy in 2005. To assess trends in surgical route and perioperative outcomes of treatment for endometrial cancer from 2008 through 2014, investigators queried a large database encompassing 750 U.S. hospitals (>12,000 women; mean age, 62; mean body-mass index [BMI], 35 m/k2; proportion with BMI ≥40, 27%).
During the study period, use of minimally invasive surgery rose from 24% to 71% of procedures (P<0.001), and the proportion of women with any complication fell…